Here’s What You Need To Know About Aviva Plc And RSA Insurance Group Plc!

Here is why I believe that shares in both RSA Insurance Group Plc (LON: RSA) and Aviva Plc (LON: AV) could be worth holding on to.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Aviva shares could be worth clinging onto!

Looking at the grand scheme of things, the stop-start performance of Aviva (LSE: AV) shares during the last 18 months will have probably left most investors feeling cheated. However, there have been some improvements in the underlying business of late that are worth taking stock of.

First and foremost, the “rights issue in disguise” acquisition of Friends Life has had a notably positive effect upon the group’s regulatory capital position, which is positive in light of the looming implementation date of the EU’s more stringent Solvency II capital regime in January 2016.  

In addition, the addition of Friends Life net assets dilutes the leverage of Aviva’s balance sheet, offers up to £225 million in annual cost savings and also boosts the cash-generative potential of the group. In short, with integration risks set aside, the acquisition is supportive of management’s strategic objectives of increasing cash flow and growth.   

Secondly, Aviva will eventually benefit from a gradual increase in investment income as interest rates rise and this feeds through to the yields of longer dated US & UK fixed income instruments.

While non-life insurance shares have already begun to benefit from changes in interest rate expectations, it is possible that we could soon see a spillover into the life and pensions side of the market as forward valuations rise elsewhere.

However, having said this, further weakness in the shares cannot be completely ruled out as a possibility in the near term, given that concerns remain over whether or not management can successfully integrate Friends Life into the existing group.

I am minded to think the management team can, and that the naysayers will eventually be proven wrong. It is also possible that the lion’s share of this concern over integration is already priced into the shares, given that the current 9.6x forward price to earnings valuation provides a 20% discount to the sector average of 11.8x.

So, to sum up on Aviva, it seems that for those who have the requisite time-frame of 2-3 years available, the shares could be worth holding onto. Particularly when we consider that the long-term investment case remains strong, while the shares trade at a discount to their peer group in the present day.

Only time will tell…

RSA Shares Could Also Be Worth Keeping For A Rainy Day…

The market was quick to dump RSA (LSE: RSA) shares this week after Zurich dropped its proposed bid for the group. While a persistent lack of returns from the shares means that some investors probably shouldn’t be blamed for this, I cannot help but think that they are still worth holding on to.

As a general insurer, with a short-term investment exposure, RSA is one of those that could see higher interest rates provide a meaningful boost to its bottom line sooner rather than later.

Also, while progress may have been slow to date, management have taken lots of positive action to rejuvenate the business.

This has resulted in the group’s combined ratio reducing steadily, something which should continue as losses within the Irish division dissipate further, while balance sheet leverage has also improved markedly.

Total debt/equity now sits at 0.32x and gearing at 24.5% for RSA, while the £1.2 billion in debt that the group does hold exists purely to act as regulatory capital.

In addition, RSA’s regulatory capital coverage ratio sits at 1.3x which means that unless regulators decide to dispute the methodology employed by the group to calculate this, it should be able to meet the requirements of the EU’s new Solvency II capital regime in January 2016.

In terms of valuations, the shares currently trade on a forward earnings multiple of 12.9x, which is a significant discount to the 17.8x sector average. This is while on a Price/Tangible Net Asset Value basis, RSA’s 1.4x multiple also compares very favourably against a 2.5x sector average.

With all things considered, it seems that the future for RSA Insurance may not be quite so bleak after all, particularly after looking at the valuation metrics.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Skinner has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »